Peripapillary and Macular Choroidal Vascularity Index in Eyes with Fuchs’ Uveitis

References

• Hovakimyan A, Baglivo E, Cunningham ET Jr. Fuchs uveitis syndrome in the developing world. Int Ophthalmol Clin. 2010;50(2):145–153. doi:10.1097/IIO.0b013e3181d2cd4c.
   PubMedGoogle Scholar
• Yalçındağ FN, Özdal PC, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I, BUST Study Group. Demographic and clinical characteristics of uveitis in Turkey: the first national registry report. Ocul Immunol Inflamm. 2018;26(1):17–26. doi:10.1080/09273948.2016.1196714.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ji Y. A literature review on fuchs uveitis syndrome: an update. Surv Ophthalmol. 2019 Oct 14:pii: S0039-6257(19) 30282–6. doi:10.1016/j.survophthal.2019.10.003.
   PubMed Web of Science ®Google Scholar
• Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubellavirus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138:46–54. doi:10.1016/j.ajo.2004.02.055.
   PubMed Web of Science ®Google Scholar
• Barequet IS, Li Q, Wang Y, O’Brien TP, Hooks JJ, Stark WJ. Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol. 2000;129:672–673. doi:10.1016/S0002-9394(00)00409-8.
   PubMed Web of Science ®Google Scholar
• Schwab IR. The epidemiologic association of fuchs’ heterochromie iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol. 1991;111:356–362. doi:10.1016/S0002-9394(14)72322-0.
   PubMed Web of Science ®Google Scholar
• Chan NS, Chee SP, Caspers LB. B. Clinical features of CMV-associated anterior uveitis. Ocul Immunol Inflamm. 2018;26:107–115. doi:10.1080/09273948.2017.1394471.
   PubMed Web of Science ®Google Scholar
• Norrsell K, Sjödell L. Fuchs’ heterochromic uveitis: a longitudinal clinical study. Acta Ophthalmol. 2008;86(1):58–64. doi:10.1111/j.1600-0420.2007.00990.x.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Güney-Tefekli E, Kamaci-Duman F, Corum I. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am J Ophthalmol. 2009;148(4):510–515. doi:10.1016/j.ajo.2009.04.007.
   PubMed Web of Science ®Google Scholar
• Mohamed Q, Zamir E. Update on fuchs’ uveitis syndrome. Curr Opin Ophthalmol. 2005;16(6):356–363. doi:10.1097/01.icu.0000187056.29563.8d.
   PubMedGoogle Scholar
• Bouchenaki N, Herbort CP. Fluorescein angiographic findings and clinical features in Fuchs’ uveitis. Int Ophthalmol. 2010;30:511–519. doi:10.1007/s10792-010-9366-z.
   PubMedGoogle Scholar
• Zarei M, Darabeigi S, Mehrpour M, Roohipoor R, Ghassemi H, Ebrahimiadib N. Fuchs’ uveitis in Iranian patients: a review of 89 eyes. Ocul Immunol Inflamm. 2019;27:1077–1085. doi:10.1080/09273948.2018.1500612.
   PubMed Web of Science ®Google Scholar
• Özdamar Erol YMD, İnanç MMD, Özdal PMD. Fuchs’ uveitis: is it different from what we know? Ocul Immunol Inflamm. 2020 Aug 24:1–6. doi:10.1080/09273948.2020.1795207.
   PubMed Web of Science ®Google Scholar
• Przybyś M, Brydak-Godowska J, Kęcik D. Subfoveal choroidal thickness and its intereye differences in fuchs uveitis syndrome evaluated using optical coherent tomography. Ocul Immunol Inflamm. 2020 Jan;16:1–6. doi:10.1080/09273948.2019.1699579.
   Google Scholar
• Cerquaglia A, Iaccheri B, Fiore T, et al. Full-thickness choroidal thinning as a feature of fuchs uveitis syndrome: quantitative evaluation of the choroid by enhanced depth imaging optical coherence tomography in a cohort of consecutive patients. Graefes Arch Clin Exp Ophthalmol. 2016;254(10):2025–2031. doi:10.1007/s00417-016-3475-y.
   PubMed Web of Science ®Google Scholar
• Balci O, Ozsutcu M. Evaluation of retinal and choroidal thickness in fuchs’ uveitis syndrome. J Ophthalmol. 2016;2016:1657078. doi:10.1155/2016/1657078.
   PubMed Web of Science ®Google Scholar
• Kardes E, Sezgin Akçay BI, Unlu C, Ergin A. Choroidal thickness in eyes with fuchs uveitis syndrome. Ocul Immunol Inflamm. 2017;25(2):259–266. doi:10.3109/09273948.2015.1115877.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Salman M, Tan KA, et al. Choroidal vascularity index (CVI)–a novel optical coherence tomography parameter for monitoring patients with panuveitis? PLoS One. 2016;11;11(1):e0146344. doi:10.1371/journal.pone.0146344.
   Web of Science ®Google Scholar
• Betzler BK, Ding J, Wei X, et al. Choroidal vascularity index: a step towards software as a medical device. Br J Ophthalmol. 2021 Jan 29;bjophthalmol-2021-318782. doi: 10.1136/bjophthalmol-2021-318782. Epub ahead of print. PMID: 33514528.
   Web of Science ®Google Scholar
• Kim RY, Chung DH, Kim M, Park YH. Use of choroidal vascularity index for choroidal structural evaluation in central serous chorioretinopathy with choroidal neovascularization. Retina. 2020;40(7):1395–1402. doi:10.1097/IAE.0000000000002585.
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Veronese C, Bernabei F, et al. Choroidal vascular changes in multiple evanescent white dot syndrome. Ocul Immunol Inflamm 2021 17;29(2):340–345. doi:10.1080/09273948.2019.1678650.
   PubMed Web of Science ®Google Scholar
• Toniolo JT, Hall AJ, Smith JG, Levy J, Lim LL. Risk factors for glaucoma in a cohort of patients with fuchs heterochromic iridocyclitis. Ocul Immunol Inflamm. 2017;25(6):753–759. doi:10.1080/09273948.2016.1199712.
   PubMed Web of Science ®Google Scholar
• Rivir-Rallatos C. Fuchs’ heterochromic iridocylitis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. 1 ed. USA: Saunders; 2002:693–700.
   Google Scholar
• Rutzen AR, Raizman MB. Fuchs’ heterochromic iridocyclitis. In: Albert DM, Jakobiec FA, Miller JW, eds. Albert & Jakobiec’s Principles and Practice of Ophthalmology. Philadelphia, PA: Edinburgh; 2008:1231–1243. Saunders/Elsevier.
   Google Scholar
• Kreps EO, Derveaux T, De Keyser F, Kestelyn P. Fuchs’ uveitis syndrome: no longer a syndrome? Ocul Immunol Inflamm. 2016;24(3):348–357. doi:10.3109/09273948.2015.1005239.
   PubMed Web of Science ®Google Scholar
• Singh SR, Vupparaboina KK, Goud A, Dansingani KK, Chhablani J. Choroidal imaging biomarkers. Surv Ophthalmol. 2019;64(3):312–333. doi:10.1016/j.survophthal.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Kim M, Kim H, Kwon HJ, Kim SS, Koh HJ, Lee SC. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci 2013 5;54(9):6033–6039. doi:10.1167/iovs.13-12231.
   PubMed Web of Science ®Google Scholar
• Ishikawa S, Taguchi M, Muraoka T, Sakurai Y, Kanda T, Takeuchi M. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet’s disease. Br J Ophthalmol. 2014;98(11):1508–1513. doi:10.1136/bjophthalmol-2014-305333.
   PubMed Web of Science ®Google Scholar
• Onal S, Uludag G, Oray M, et al. quantitative analysis of structural alterations in the choroid of patients with active Behçet uveitis. Retina. 2018;38(4):828–840. doi:10.1097/IAE.0000000000001587.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Kim JH, Lee BR. Choroidal change in acute anterior uveitis associated with human leukocyte antigen-B27. PLoS One. 2017 Jun 28;12(6):e0180109. doi:10.1371/journal.pone.0180109.
   PubMed Web of Science ®Google Scholar
• Basarir B, Celik U, Altan C, Celik NB. Choroidal thickness changes determined by EDI-OCT on acute anterior uveitis in patients with HLA-B27-positive ankylosing spondylitis. Int Ophthalmol. 2018;38:307–312.
   PubMed Web of Science ®Google Scholar
• Kim M, Kim RY, Park YH. Choroidal vascularity index and choroidal thickness in human leukocyte antigen-B27-associated uveitis. Ocul Immunol Inflamm. 2019;27(8):1280–1287. doi:10.1080/09273948.2018.1530364.
   PubMed Web of Science ®Google Scholar
• Da Silva FT, Sakata VM, Nakashima A, et al. Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2013;97(1):70–74. doi:10.1136/bjophthalmol-2012-302089.
   PubMed Web of Science ®Google Scholar
• Coskun E, Gurler B, Pehlivan Y, et al. Enhanced depth imaging optical coherence tomography findings in Behçet disease. Ocul Immunol Inflamm. 2013;21(6):440–445. doi:10.3109/09273948.2013.817591.
   PubMed Web of Science ®Google Scholar
• Liu S, Du L, Zhou Q, et al. The Choroidal vascularity index decreases and choroidal thickness increases in vogt-koyanagi-harada disease patients during a recurrent anterior uveitis attack. Ocul Immunol Inflamm. 2018;26(8):1237–1243. doi:10.1080/09273948.2017.1343357.
   PubMed Web of Science ®Google Scholar
• Ozer MD, Batur M, Tekin S, Seven E, Kebapci F. Choroid vascularity index as a parameter for chronicity of Fuchs’ uveitis syndrome. Int Ophthalmol. 2020;40(6):1429–1437. doi:10.1007/s10792-020-01309-4.
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Blood supply of the optic nerve head. Ophthalmologica. 1996;210(5):285–295. doi:10.1159/000310727. PMID: 8878212.
   PubMed Web of Science ®Google Scholar
• Goker YS, Ozdal PC, Erol YO, Kızıltoprak H, Karatepe MS. Evaluation of radial peripapillary capillary density in patients with Fuchs uveitis syndrome. Graefes Arch Clin Exp Ophthalmol. 2019;257(12):2735–2742. doi:10.1007/s00417-019-04491-z.
   PubMed Web of Science ®Google Scholar
• Esfandiari H, Loewen NA, Hassanpour K, et al. Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C. F1000Res. 2018;22(7):876. doi:10.12688/f1000research.15244.1.
   Google Scholar